Consolidated Statements of Cash Flows (Unaudited) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Operating Activities
Net income	$ 6,432	$ 8,186
Adjustments to reconcile net income to net cash provided (used) by operating activities
Deferred income taxes		1,459
Provision for credit losses		550
Depreciation and amortization	2,100	2,130
Amortization and accretion of premiums/discounts on investment securities	424	527
Amortization of operating lease right-of-use assets	(8)	(43)
Share-based compensation expense	593	159
Originations on loans held for sale	(53,129)	(56,347)
Proceeds on loans held for sale	55,362	50,381
(Increase) in value of bank-owned life insurance	(160)	(224)
Realized loss (gain) on derivative instruments	(678)	(253)
Realized loss (gain) on loans sold	(1,438)	(1,344)
Realized loss (gain) on sale of foreclosed assets		8
Realized loss (gain) on BOLI mortality		(1,196)
Realized loss (gain) on servicing rights	(20)	38
Net change in:
Accrued interest receivable	(449)	(114)
Other assets	(1,071)	2,052
Accrued expenses and other liabilities	4,031	(8,352)
Net cash provided (used) by operating activities	11,989	(2,383)
Investing Activities
Proceeds from sales of trading investment securities	5,502
Purchases of trading investment securities	(10,008)
Proceeds from maturities of investment securities available-for-sale	10,818	16,139
Proceeds from calls of investment securities held-to-maturity	251	126
Proceeds from maturities and paydowns of investment securities held-to-maturity	7,043	7,578
Net (increase) decrease in loans	(40,223)	(42,801)
Net (increase) decrease in FHLB stock	5,075	(225)
Proceeds from BOLI mortality claim		2,828
Purchases of premises and equipment	(881)	(923)
Proceeds from sales of foreclosed assets	34	22
Net cash provided (used) by investing activities	(22,389)	(17,256)
Financing Activities
Net increase (decrease) in deposits	189,358	116,494
Net increase (decrease) in short-term borrowings	240,830	(5,935)
Repayments of long-term debt	1
Cash dividends paid on common stock	(3,757)	(3,620)
Repurchase of common stock	(153)	(361)
Net cash provided (used) by financing activities	426,279	106,578
Net change in cash and cash equivalents	415,879	86,939
Cash and cash equivalents at beginning of period	129,893	58,242
Cash and cash equivalents at end of period	545,772	145,181
Supplemental Cash Flow Disclosures
Interest paid	22,339	15,167
Income taxes paid	1
Cash dividends declared, not paid	3,763	3,620
Supplemental Disclosures of Noncash Investing and Financing Activities
Loan collateral transferred to foreclosed assets	(5)
Right-of-use assets obtained in exchange for new operating lease liabilities, net	108	$ 257
Change in fair value hedges presented within residential real estate loans and other assets	$ 268